Reported Earlier, Moderna and Cenra Healthcare Join Forces to Promote COVID-19 and Respiratory Vaccines in Taiwan
Portfolio Pulse from Benzinga Newsdesk
Moderna, Inc. and Cenra Healthcare have entered a joint agreement to co-promote Moderna's mRNA respiratory vaccine portfolio, including the COVID-19 vaccine Spikevax®, in Taiwan. The agreement is effective until July 31, 2027.
October 01, 2024 | 7:09 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Moderna has partnered with Cenra Healthcare to promote its mRNA respiratory vaccines in Taiwan, potentially expanding its market reach and increasing vaccine sales.
The partnership with Cenra Healthcare allows Moderna to leverage local expertise in Taiwan, potentially increasing the distribution and sales of its mRNA vaccines, including Spikevax®. This could positively impact Moderna's revenue and market presence in the region.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90